Basel Medical (BMGL) EPS (Basic) (2024 - 2025)

Basel Medical (BMGL) posted EPS (Basic) of $0.01 for Q4 2025, up 143.78% sequentially from -$0.02 in Q4 2024, and up 143.78% YoY from $0.0 in Q4 2024.

Basel Medical (BMGL) EPS (Basic) (2024 - 2025) Analysis & Trends

Basel Medical (BMGL) has 2 years of EPS (Basic) data on file, last reported at $0.01 in Q4 2025.

  • Quarterly EPS (Basic) rose 143.78% year-over-year to $0.01 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.01 (changed N/A YoY) and the FY2025 annual result came in at -$0.31, down 130.57% from the prior year.
  • EPS (Basic) improved to $0.01 in Q4 2025 per BMGL's latest filing, from -$0.02 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.01 in Q4 2025, with the low at -$0.02 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn 8.31
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 1.76
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 8.09
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn 4.08
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 0.16
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 1.67
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 5.71
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 0.51
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn -2.93
10 Basel Medical 133.19 Mn 130.39 Mn - 0.01

Historic Data

Download Data
DateValue
Dec 31, 2025 0.01
Dec 31, 2024 -0.02